+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Patient Monitoring Devices Market by Product Type and End User: Global Opportunity Analysis and Industry Forecast, 2020-2027

  • PDF Icon

    Report

  • 319 Pages
  • July 2020
  • Region: Global
  • Allied Market Research
  • ID: 5141658
The global patient monitoring devices market was $25,768.56 million in 2019, and is projected to reach $44,861.56 million by 2027 at a CAGR of 4.4% from 2020 to 2027. Patient monitoring devices are used to observe vital signs such as respiration and heart rate of patients. With advancements in wireless technology, these devices can be used remotely to monitor physiological parameters of patients. Patient monitoring devices such as pulse oximeters, capnographs, and cardiac monitors are increasingly being used in hospitals, clinics, and various outpatient centers. These devices are commonly used during minor and major surgeries to monitor physiological signs of patients and intervene, if any complication occurs. These devices can also help healthcare professionals to monitor vital signs of multiple patients at the same time. Some of these devices are also used to alert physicians, in case the parameter levels are either above or below the limit set by physicians. Moreover, with the help of remote monitoring devices, physicians can remotely monitor physiological parameters such as blood glucose level, blood pressure, and heart rate; and accordingly provide appropriate treatment for patients.



The market is expected to witness a significant growth during the forecast period. The growth can be attributed to increase in geriatric population and rise in adoption of remote patient monitoring devices. Rise in prevalence of patients suffering from different lifestyle diseases such as diabetes, cancer, and atherosclerosis also contribute toward the growth of the patient monitoring devices market. Moreover, collaborations between companies, hospitals, and academic institutions are expected to increase the market revenue and, therefore, boost market growth. However, cost associated with these products and lack of awareness among patients hinders market growth. Moreover, government regulations and reimbursement issues also restrain growth of the patient monitoring devices market.

The global patient monitoring devices market is segmented on the basis of product type, end user, and region. By product type, it is divided into hemodynamic monitoring, neuromonitoring, cardiac monitoring, fetal & neonatal monitoring, respiratory monitoring, multi-parameter monitoring, remote patient monitoring, weigh monitoring, and temperature monitoring devices. On the basis of end user it is segmented into hospitals, home settings, and ambulatory surgical centers. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

KEY BENEFITS FOR STAKEHOLDERS
  • The report provides an extensive analysis of the current market trends and future estimations in the patient monitoring devices market.
  • The market scenario is comprehensively analyzed with respect to the device types and end users.
  • The market estimations are based on high-end analysis of the key developments from 2019-2027.
  • Recent developments and key manufacturers are listed to understand the competitive market scenario.
  • In-depth geographical analysis provides an understanding of the regional market, which assists in strategic business planning.

KEY MARKET SEGMENTS

By Product
  • Hemodynamic Monitoring Devices
  • Blood Glucose
  • Cholesterol
  • Blood Gas & Electrolyte Analyzers/Monitors
  • Blood Pressure
  • Neuromonitoring Devices
  • Electroencephalograph (EEG) Devices
  • Transcranial Dopplers (TCD)
  • Magnetoencephalography (MEG) Devices
  • Intracranial Pressure Monitors (ICP)
  • Cerebral Oximeters
  • Cardiac Monitoring Devices
  • Electrocardiogram (ECG) Devices
  • Holter Monitor
  • Event Monitors
  • Others
  • Fetal & Neonatal Monitoring Devices
  • Ultrasound
  • Electronic Fetal Monitoring Devices
  • Fetal Doppler Monitoring Devices
  • Other Fetal & Neonatal Monitoring Devices
  • Respiratory Monitoring Devices
  • Capnographs
  • Spirometers
  • Sleep Apnea Monitor
  • Pulse Oximeters
  • Multiparameter Monitoring Devices
  • High Acuity
  • Mid Acuity
  • Low Acuity
  • Remote Patient Monitoring Devices
  • Weight Monitoring Devices
  • Temperature Monitoring Devices

By End User
  • Hospitals & Clinics
  • Home Settings
  • Ambulatory Surgical Centers (ASCs)

By Region
  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Rest of Europe
  • Asia-Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia-Pacific- LAMEA
  • Brazil
  • Turkey
  • Venezuela
  • Saudi Arabia
  • Rest of LAMEA

List of key players profiled in the report
  • Medtronic, Inc.
  • Biotronik
  • F. Hoffmann-La Roche Ltd.
  • GE Healthcare Ltd
  • Masimo Corporation
  • Nihon Kohden Corporation
  • Johnson and Johnson
  • Omron Healthcare Co. Ltd.
  • Abbott Laboratories
  • Koninklijke Philips N.V.

Table of Contents

Chapter 1. Introduction
1.1. Report Description
1.2. Key Benefits
1.3. Key Market Segments
1.4. Research Methodology
1.4.1. Secondary Research
1.4.2. Primary Research
1.4.3. Analyst Tools and Models
Chapter 2. Executive Summary
2.1. CXO Perspective
Chapter 3. Market Overview
3.1. Market Definition and Scope
3.2. Key Findings
3.2.1. Top Investment Pockets
3.2.2. Top Winning Strategies
3.3. Top Player Positioning
3.4. Porter’s Five Forces Analysis
3.5. Covid-19 Impact on the Market
3.6. Government Regulations
3.6.1. U.S. Fda
3.6.2. European Conformity (Ce) Mark
3.6.3. Ministry of Health, Labor, and Welfare (Mhlw)
3.7. Reimbursement Scenarios
3.8. Clinical Trials
3.9. Patent Analysis
3.9.1. Patents Registered/Approved, 2011–2020
3.9.2. Patents Registered/Approved, by Applicants, 2011–2020
3.9.3. U.S. Patent Analysis, by Market Applicants
3.9.4. Pct Patent Analysis, by Market Applicants
3.9.5. Europe Patent Analysis, by Market Applicants
3.9.6. China Patent Analysis, by Market Applicants
3.9.7. Australia Patent Analysis by Market Applicants
3.10. Market Dynamics
3.10.1. Drivers
3.10.1.1. Rise in Prevalence of Lifestyle Diseases
3.10.1.2. Increase in Geriatric Population
3.10.1.3. Rise in the Adoption of Remote Patient Monitoring Devices
3.10.2. Restraints
3.10.2.1. Government Regulations and Reimbursement Issues
3.10.2.2. Limited Awareness and High Costs
3.10.3. Opportunities
3.10.3.1. Untapped Markets in Developing Countries
3.10.3.2. Technological Advancements
Chapter 4. Patient Monitoring Devices Market, by Product Type
4.1. Overview
4.1.1. Market Size and Forecast
4.2. Hemodynamic Monitoring Devices
4.2.1. Key Market Trends and Opportunity
4.2.2. Market Size and Forecast
4.2.3. Market Share Analysis, by Country
4.2.4. Blood Glucose Monitors
4.2.4.1. Market Size and Forecast
4.2.5. Blood Gas and Electrolyte Analyzers/Monitors
4.2.5.1. Market Size and Forecast
4.2.6. Blood Pressure Monitors
4.2.6.1. Market Size and Forecast
4.3. Neuromonitoring Devices
4.3.1. Key Market Trends and Opportunities
4.3.2. Market Size and Forecast
4.3.3. Market Share Analysis, by Country
4.3.4. Electroencephalograph (Eeg) Devices
4.3.4.1. Market Size and Forecast
4.3.5. Transcranial Dopplers (Tcd)
4.3.5.1. Market Size and Forecast
4.3.6. Magnetoencephalograph (Meg) Devices
4.3.6.1. Market Size and Forecast
4.3.7. Intracranial Pressure Monitors (Icp)
4.3.7.1. Market Size and Forecast
4.3.8. Cerebral Oximeters
4.3.8.1. Market Size and Forecast
4.4. Cardiac Monitoring Devices
4.4.1. Key Market Trends and Opportunities
4.4.2. Market Size and Forecast
4.4.3. Market Share Analysis, by Country
4.4.4. Electrocardiogram (Ecg) Devices
4.4.4.1. By Type
4.4.4.2. By Lead Type
4.4.4.3. Market Size and Forecast
4.4.5. Holter Monitors
4.4.5.1. Market Size and Forecast
4.4.6. Event Monitors
4.4.6.1. By Type
4.4.6.2. By Technology
4.4.6.3. Market Size and Forecast
4.4.7. Others (Implantable Loop Recorder, Cardiac Output Monitor and Others)
4.4.7.1. Market Size and Forecast
4.5. Fetal Neonatal Monitoring Devices
4.5.1. Key Market Trends and Opportunities
4.5.2. Market Size and Forecast
4.5.3. Market Share Analysis, by Country
4.5.4. Ultrasound
4.5.4.1. Market Size and Forecast
4.5.5. Electronic Fetal Monitoring Devices
4.5.5.1. Market Size and Forecast
4.5.6. Fetal Doppler Monitoring Devices
4.5.6.1. Market Size and Forecast
4.5.7. Others
4.5.7.1. Market Size and Forecast
4.6. Respiratory Monitors
4.6.1. Key Market Trends and Opportunities
4.6.2. Market Size and Forecast
4.6.3. Market Share Analysis, by Country
4.6.4. Capnographs
4.6.4.1. Market Size and Forecast
4.6.5. Pulse Oximeters
4.6.5.1. Market Size and Forecast
4.6.6. Sleep Apnea Monitors
4.6.6.1. Market Size and Forecast
4.6.7. Spirometers
4.6.7.1. Market Size and Forecast
4.7. Multiparameter Monitoring Devices
4.7.1. Key Market Trends and Opportunities
4.7.2. Market Size and Forecast
4.7.3. Market Share Analysis, by Country
4.7.4. High Acuity
4.7.4.1. Market Size and Forecast
4.7.5. Mid Acuity
4.7.5.1. Market Size and Forecast
4.7.6. Low Acuity
4.7.6.1. Market Size and Forecast
4.8. Remote Patient Monitoring Devices
4.8.1. Key Market Trends and Opportunities
4.8.2. Market Size and Forecast
4.8.3. Market Share Analysis, by Country
4.9. Weight Monitoring Devices
4.9.1. Key Market Trends and Opportunities
4.9.2. Market Size and Forecast
4.9.3. Market Share Analysis, by Country
4.10. Temperature Monitoring Devices
4.10.1. Key Market Trends and Opportunities
4.10.2. Market Size and Forecast
4.10.3. Market Share Analysis, by Country
4.11. Urine Output Monitoring
4.11.1. Key Market Trends and Opportunities
4.11.2. Market Size and Forecast
4.11.3. Market Share Analysis, by Country
Chapter 5. Patient Monitoring Devices Market, by End-user
5.1. Overview
5.1.1. Market Size and Forecast
5.2. Hospitals
5.2.1. Market Size and Forecast
5.2.2. Market Share Analysis, by Country
5.3. Home Settings
5.3.1. Market Size and Forecast
5.3.2. Market Share Analysis, by Country
5.4. Ambulatory Surgical Centers (Ascs)
5.4.1. Market Size and Forecast
5.4.2. Market Share Analysis, by Country
Chapter 6. Patient Monitoring Devices Market, by Region
6.1. Overview
6.1.1. Market Size and Forecast
6.2. North America
6.2.1. Key Opportunities and Forecast
6.2.2. Market Size and Forecast
6.2.2.1. U.S. Market Size and Forecast
6.2.2.2. Canada Market Size and Forecast
6.2.2.3. Mexico Market Size and Forecast
6.3. Europe
6.3.1. Key Opportunities and Forecast
6.3.2. Market Size and Forecast
6.3.2.1. Germany Market Size and Forecast
6.3.2.2. France Market Size and Forecast
6.3.2.3. UK Market Size and Forecast
6.3.2.4. Italy Market Size and Forecast
6.3.2.5. Spain Market Size and Forecast
6.3.2.6. Rest of Europe Market Size and Forecast
6.4. Asia-Pacific
6.4.1. Key Opportunities and Forecast
6.4.2. Market Size and Forecast
6.4.2.1. Japan Market Size and Forecast
6.4.2.2. China Market Size and Forecast
6.4.2.3. Australia Market Size and Forecast
6.4.2.4. India Market Size and Forecast
6.4.2.5. South Korea Market Size and Forecast
6.4.2.6. Rest of Asia-Pacific Market Size and Forecast
6.5. LAMEA
6.5.1. Key Opportunities and Forecast
6.5.2. Market Size and Forecast
6.5.2.1. Brazil Market Size and Forecast
6.5.2.2. Turkey Market Size and Forecast
6.5.2.3. Venezuela Market Size and Forecast
6.5.2.4. Saudi Arabia Market Size and Forecast
6.5.2.5. Rest of LAMEA Market Size and Forecast
Chapter 7. Company Profiles
7.1. Abbott Laboratories
7.1.1. Company Overview
7.1.2. Company Snapshot
7.1.3. Operating Business Segments
7.1.4. Product Portfolio
7.1.5. Business Performance
7.1.6. Key Strategic Moves and Developments
7.2. Biotronik Se & Co. Kg
7.2.1. Company Overview
7.2.2. Company Snapshot
7.2.3. Operating Business Segments
7.2.4. Product Portfolio
7.2.5. Key Strategic Moves and Developments
7.3. General Electric Company (Ge Healthcare)
7.3.1. Company Overview
7.3.2. Company Snapshot
7.3.3. Operating Business Segments
7.3.4. Product Portfolio
7.3.5. Business Performance
7.3.6. Key Strategic Moves and Developments
7.4. F. Hoffmann-La Roche Ltd.
7.4.1. Company Overview
7.4.2. Company Snapshot
7.4.3. Operating Business Segments
7.4.4. Product Portfolio
7.4.5. Business Performance
7.4.6. Key Strategic Moves and Developments
7.5. Johnson & Johnson
7.5.1. Company Overview
7.5.2. Company Snapshot
7.5.3. Operating Business Segments
7.5.4. Product Portfolio
7.5.5. Business Performance
7.5.6. Key Strategic Moves and Developments
7.6. Koninklijke Philips N. V. (Philips Healthcare)
7.6.1. Company Overview
7.6.2. Company Snapshot
7.6.3. Operating Business Segments
7.6.4. Product Portfolio
7.6.5. Business Performance
7.6.6. Key Strategic Moves and Developments
7.7. Masimo Corporation
7.7.1. Company Overview
7.7.2. Company Snapshot
7.7.3. Product Portfolio
7.7.4. Business Performance
7.7.5. Key Strategic Moves and Developments
7.8. Medtronic plc.
7.8.1. Company Overview
7.8.2. Company Snapshot
7.8.3. Operating Business Segments
7.8.4. Medtronic Offers Following Patient Monitoring Devices
7.8.5. Business Performance
7.8.6. Key Strategic Moves and Developments
7.9. Nihon Kohden Corporation
7.9.1. Company Overview
7.9.2. Company Snapshot
7.9.3. Operating Business Segments
7.9.4. Product Portfolio
7.9.5. Business Performance
7.9.6. Key Strategic Moves and Developments
7.10. Omron Corporation
7.10.1. Company Overview
7.10.2. Company Snapshot
7.10.3. Operating Business Segments
7.10.4. Product Portfolio
7.10.5. Business Performance
7.10.6. Key Strategic Moves and Development

Methodology

The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.

They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.

They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic news articles and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast

Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.

Loading
LOADING...